Atlas Trials

A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach

Clinical trial NCT00038415 · TERMINATED

Trial details

NCT number
NCT00038415
Sponsor
M.D. Anderson Cancer Center
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Leukemia, Lymphocytic, Chronic
Start date
2001-12-01
Primary completion
2004-07-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.